{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:40:38Z","timestamp":1789764038475,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101573","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:34:59Z","timestamp":1755747299000},"page":"101573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic HSV vectors"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-7503","authenticated-orcid":false,"given":"Yoshitaka","family":"Miyagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Hayashita-Kinoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Glorioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101573_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ymthe.2019.01.019","article-title":"Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy","volume":"27","author":"Davies","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib2","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1128\/JVI.72.9.7137-7143.1998","article-title":"An enhanced packaging system for helper-dependent herpes simplex virus vectors","volume":"72","author":"Stavropoulos","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101573_bib3","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1128\/JVI.01633-10","article-title":"A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection","volume":"84","author":"Uchida","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101573_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/mt.2012.211","article-title":"Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus","volume":"21","author":"Uchida","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib5","doi-asserted-by":"crossref","first-page":"E1632","DOI":"10.1073\/pnas.1423556112","article-title":"Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity","volume":"112","author":"Miyagawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101573_bib6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0306-4522(97)00513-7","article-title":"A gamma34.5 mutant of herpes simplex 1 causes severe inflammation in the brain","volume":"83","author":"McMenamin","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtm.2025.101573_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exer.2016.05.003","article-title":"Primate neural retina upregulates IL-6 and IL-10 in response to a herpes simplex vector suggesting the presence of a pro-\/anti-inflammatory axis","volume":"148","author":"Sauter","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101573_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/13550280903473452","article-title":"A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system","volume":"15","author":"Zeier","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.omtm.2025.101573_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/sj.gt.3300766","article-title":"Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons","volume":"5","author":"Krisky","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003547","article-title":"Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia","volume":"9","author":"van Velzen","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2025.101573_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00536-18","article-title":"Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression","volume":"92","author":"Han","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101573_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.omtm.2017.06.001","article-title":"Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes","volume":"6","author":"Miyagawa","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101573_bib13","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41598-017-01635-1","article-title":"Engineered HSV vector achieves safe long-term transgene expression in the central nervous system","volume":"7","author":"Verlengia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101573_bib14","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1128\/JVI.01008-06","article-title":"The virion host shutoff protein (UL41) of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase A","volume":"80","author":"Taddeo","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101573_bib15","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1073\/pnas.0510712103","article-title":"The U(L)41 protein of herpes simplex virus 1 degrades RNA by endonucleolytic cleavage in absence of other cellular or viral proteins","volume":"103","author":"Taddeo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101573_bib16","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1128\/JVI.01819-09","article-title":"Evidence for translational regulation by the herpes simplex virus virion host shutoff protein","volume":"84","author":"Saffran","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101573_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5615","article-title":"Generation of replication-competent and -defective HSV vectors","volume":"2011","author":"Goins","year":"2011","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.omtm.2025.101573_bib18","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.gt.3300755","article-title":"Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications","volume":"5","author":"Krisky","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sj.gt.3300882","article-title":"Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo","volume":"6","author":"Marconi","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbpb.2006.06.001","article-title":"Luciferase from the Italian firefly Luciola italica: molecular cloning and expression","volume":"145","author":"Branchini","year":"2006","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"10.1016\/j.omtm.2025.101573_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gt.2014.19","article-title":"Herpes simplex virus vector-mediated gene transfer of kynurenine aminotransferase improves detrusor overactivity in spinal cord-injured rats","volume":"21","author":"Jia","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib22","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","article-title":"Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors","volume":"110","author":"Srivastava","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.omtm.2025.101573_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1744-8069-10-49","article-title":"IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats","volume":"10","author":"Zheng","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.omtm.2025.101573_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jpn3.12326","article-title":"Adeno-associated viral vector gene therapy: Challenges for the paediatric hepatologist","volume":"79","author":"Jagadisan","year":"2024","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.omtm.2025.101573_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jvh.13919","article-title":"Hepatitis after gene therapy, what are the possible causes?","volume":"31","author":"Maina","year":"2024","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.omtm.2025.101573_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012413","article-title":"Quantitative comparison of constitutive promoters in human ES cells","volume":"5","author":"Norrman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101573_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010611","article-title":"Systematic comparison of constitutive promoters and the doxycycline-inducible promoter","volume":"5","author":"Qin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101573_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1521-2254(199907\/08)1:4<280::AID-JGM45>3.0.CO;2-L","article-title":"Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle","volume":"1","author":"Akkaraju","year":"1999","journal-title":"J. Gene Med."},{"key":"10.1016\/j.omtm.2025.101573_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/hum.1997.8.4-371","article-title":"Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors","volume":"8","author":"Feero","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/hum.1997.8.4-439","article-title":"LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector","volume":"8","author":"Huard","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib31","first-page":"385","article-title":"Herpes simplex virus type 1 vector mediated gene transfer to muscle","volume":"2","author":"Huard","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0960-8966(97)00054-0","article-title":"Gene transfer to muscle using herpes simplex virus-based vectors","volume":"7","author":"Huard","year":"1997","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2025.101573_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0960-8966(98)00019-4","article-title":"Implications of maturation for viral gene delivery to skeletal muscle","volume":"8","author":"van Deutekom","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2025.101573_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-9814-2_4","article-title":"Engineering HSV-1 Vectors for Gene Therapy","volume":"2060","author":"Goins","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2025.101573_bib35","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/sj.gt.3300497","article-title":"Rapid method for construction of recombinant HSV gene transfer vectors","volume":"4","author":"Krisky","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2017.03.002","article-title":"HSV1 latent transcription and non-coding RNA: A critical retrospective","volume":"308","author":"Phelan","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.omtm.2025.101573_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/gt.2016.17","article-title":"Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread","volume":"23","author":"Shibata","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib38","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/JVI.02804-12","article-title":"Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread","volume":"87","author":"Uchida","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101573_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/1568009617666170206105855","article-title":"Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens","volume":"18","author":"Uchida","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.omtm.2025.101573_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.juro.2012.08.192","article-title":"Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-alpha blockade for bladder overactivity and nociception in rats","volume":"189","author":"Funahashi","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.omtm.2025.101573_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nbd.2012.05.005","article-title":"Gene therapy for the treatment of chronic peripheral nervous system pain","volume":"48","author":"Goins","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101573_bib42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/mt.2010.246","article-title":"HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation","volume":"19","author":"Goss","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/gt.2009.24","article-title":"HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain","volume":"16","author":"Goss","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.mad.2011.04.010","article-title":"Premature aging-related peripheral neuropathy in a mouse model of progeria","volume":"132","author":"Goss","year":"2011","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.omtm.2025.101573_bib45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1089\/hum.2015.026","article-title":"Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats","volume":"26","author":"Majima","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib46","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.juro.2010.04.066","article-title":"Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats","volume":"184","author":"Miyazato","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.omtm.2025.101573_bib47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/gt.2012.24","article-title":"Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception","volume":"20","author":"Oguchi","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.40","article-title":"An HSV-based library screen identifies PP1alpha as a negative TRPV1 regulator with analgesic activity in models of pain","volume":"3","author":"Reinhart","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101573_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/hum.2011.180","article-title":"Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception","volume":"24","author":"Yokoyama","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101573_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ana.22446","article-title":"Gene therapy for pain: results of a phase I clinical trial","volume":"70","author":"Fink","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2025.101573_bib51","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","article-title":"Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa","volume":"387","author":"Guide","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101573_bib52","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","article-title":"In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","volume":"28","author":"Gurevich","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101573_bib53","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40265-023-01921-5","article-title":"Beremagene Geperpavec: First Approval","volume":"83","author":"Dhillon","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.omtm.2025.101573_bib54","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1016\/j.cell.2023.07.031","article-title":"Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB)","volume":"186","author":"Epstein","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101573_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"}],"container-title":["Molecular Therapy Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:20:40Z","timestamp":1762615240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001688"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101573","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic HSV vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101573"}}